E. Ludwig

发表

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.

M. Leppert, R. Hegele, S. Hunt, 1993, The American journal of cardiology.

Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women.

J. Carlquist, T. Bair, J. Muhlestein, 1998, Journal of the American College of Cardiology.

DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women

Robert V Farese, I. Borecki, R. Mahley, 2002, Clinical genetics.

DNA sequence of the human apolipoprotein B gene.

R. Mahley, J. Scott, B. Mccarthy, 1987, DNA.

Uptake of Apolipoprotein E‐Containing High Density Lipoproteins by Hepatic Parenchymal Cells

R. Mahley, K. Weisgraber, J. Boyles, 1984, Arteriosclerosis.

Metabolism of Canine β‐Very Low Density Lipoproteins in Normal and Cholesterol‐Fed Dogs

R. Mahley, T. Innerarity, J. Boyles, 1988, Arteriosclerosis.

High-resolution analysis of a hypervariable region in the human apolipoprotein B gene.

B. Mccarthy, E. Ludwig, W. Friedl, 1989, American journal of human genetics.

Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred.

B. Paulweber, T. Innerarity, B. Mccarthy, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.

S. Young, R. E. Pitas, J. Witztum, 2005, Journal of lipid research.

Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.

J. Lalouel, P. Hopkins, R. Ward, 1997, Journal of lipid research.

A polymorphism in a region with enhancer activity in the second intron of the human apolipoprotein B gene.

B. Mccarthy, B. Levy-Wilson, B. Blackhart, 1991, Journal of lipid research.

Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis

Marie-Pierre Dubé, Elizabeta Nemeth, Tomas Ganz, 2004, Nature Genetics.

Nuclease-hypersensitive sites define a region with enhancer activity in the third intron of the human apolipoprotein B gene.

B. Paulweber, B. Levy-Wilson, E. Ludwig, 1992, The Journal of biological chemistry.

Comparative analysis of sequences at the 5' end of the human and mouse apolipoprotein B genes.

B. Mccarthy, B. Levy-Wilson, T. Knott, 1991, DNA and cell biology.

Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100.

B. Mccarthy, E. Ludwig, 1990, American journal of human genetics.

Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.

S. Grundy, G. Vega, H. R. Clarke, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study.

I. Borecki, A. Folsom, M. Province, 1997, Annals of epidemiology.

Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications.

J. A. López, B. Mccarthy, E. Ludwig, 1992, The Journal of biological chemistry.

Analysis of two different tandem repetitive elements within the human apolipoprotein B gene.

B. Mccarthy, E. Ludwig, K. Haubold, 1991, Journal of lipid research.

Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls.

B. Paulweber, B. Mccarthy, B Paulweber, 1990, Journal of lipid research.

Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.

S C Hunt, T D Berry, S. Hunt, 1993, American journal of hypertension.

A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

John Quackenbush, T. Nakajima, J. Lalouel, 1997, The Journal of clinical investigation.

Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis.

J M Lalouel, J. Lalouel, R. Ward, 1995, Circulation.

Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies.

J. Pankow, I. Borecki, A. Folsom, 1998, Atherosclerosis.

Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.

J L Witztum, R. Mahley, K. Weisgraber, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study.

I. Borecki, A. Folsom, M. Province, 1997, Annals of epidemiology.

Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region.

A. Marian, V. Afshar-Kharghan, E. Ludwig, 2001, Blood.

High-level lipoprotein [a] expression in transgenic mice: Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400467-JLR200evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins

S. Young, J. Witztum, R. Lawn, 2005, Journal of Lipid Research.